bioRxivImmunologyPreprint
Single cell RNA-seq uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19
M. Aznaourova, N. Schmerer, H. Janga, Z. Zhang, K. Pauck, J. Hoppe, S. M. Volkers, D. Wendisch, P. Georg, M. Guendisch, E. Mack, C. Skevaki, C. Keller, C. Bauer, W. Bertrams, A. Nist, T. Stiewe, A. D. Gruber, C. Ruppert, Y. Li, H. Garn, L. E. Sander, B. Schmeck, L. N. Schulte
Abstract
The systemic immune response to viral infection is shaped by master transcription factors such as NF{kappa}B or PU.1. Although long non-coding RNAs (lncRNAs) have been suggested as important regulators of transcription factor activity, their contributions to the systemic immunopathologies observed during SARS-CoV-2 infection have remained unknown. Here, we employed a targeted single-cell RNA-seq approach to reveal lncRNAs differentially expressed in blood leukocytes during severe COVID-19. Our results uncover the lncRNA PIRAT as a major PU.1 feedback-regulator in monocytes, governing the production of the alarmins S100A8/A9 - key drivers of COVID-19 pathogenesis. Knockout and transgene expression, combined with chromatin-occupancy profiling characterized PIRAT as a nuclear decoy RNA, diverting the PU.1 transcription factor from alarmin promoters to dead-end pseudogenes in naive monocytes. NF{kappa}B-dependent PIRAT down-regulation during COVID-19 consequently releases a transcriptional brake, fueling alarmin production. Our results suggest a major role of nuclear noncoding RNA circuits in systemic antiviral responses to SARS-CoV-2 in humans.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection
Rafeed Rahman Turjya, Md. Abdullah‐Al‐Kamran Khan, Abul Bashar Mir Md. Khademul Islam·Future VirologyPeer-reviewed·Sep 1, 2020
- The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response.
Francisco J. Enguita, Ana Lúcia Leitão, … Afshin Beheshti·bioRxiv·Mar 26, 2022
- PUM2 binds SARS-CoV-2 RNA and PUM1 mildly reduces viral RNA levels, but neither protein affects progeny virus production
Nhi Phan, Yelizaveta Zaytseva, … Paulina Pawlica·Journal of General VirologyPeer-reviewed·Sep 16, 2025
- Transcriptomic analysis of sorted lung cells revealed a proviral activity of the NF- κB pathway towards SARS-CoV-2
A. Bhargava, U. Szachnowski, … N. Jouvenet·bioRxiv·Feb 25, 2022
- The orphan receptor IL-17RD is a negative regulator of RIG-I-like receptor-dependent antiviral innate immunity and restrains SARS-CoV-2-induced lung inflammation
Firas El-Mortada, Jiunn Roy, … Marc J. Servant·bioRxiv·Sep 9, 2026
- Rapid decay of host basal mRNAs during SARS-CoV-2 infection perturbs host antiviral mRNA biogenesis and export
J. M. Burke, L. A. St Clair, … R. Parker·bioRxiv·Apr 19, 2021